transitioning from semaglutide to tirzepatide Early Dose Escalation of after Switching in Type 2 Diabetes Mellitus Switching from Semaglutide to Tirzepatide

Obesity increases the risk for some types of cancer, as well as heart disease and diabetes but over a longer time frame

The company operates on a subscription model

It's important to note that Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are FDA-approved for chronic weight management, while Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for type 2 diabetes management, though they may be used off-label for weight loss

Who should avoid using semaglutide for weight loss

Glycine is the rate-limiting factor in glutathione synthesis when paired with cysteine (NAC is a cysteine precursor)

Because metformin causes weight loss, in non-diabetics too